Metabolic Regulation Peptides Bioactive Toxin-Derived Peptides Tumor-Associated Antigen Peptides Nuclear Localization Signals (NLS) Cell-Penetrating Peptides (CPPs) Neurodegenerative Disease Research Peptides Melanogenesis Modulation Anti-Aging & Skin Remodeling Gastrin, GRP & Bombesin Peptides Somatostatin Analogs DPPIV/CD26 Peptides Kinase Activity Modulators Caspase Substrates & Inhibitors Viral Protease Substrates Antiviral Peptides Antimicrobial Peptides Cardiovascular Peptides Immunomodulatory Peptides Calcitonin & CGRP Family Peptides Incretin & Metabolic Peptides Parathyroid Hormone (PTH) Growth Hormone GnRH Analogues/Antagonists Pain and Inflammation Modulation Pituitary Hormones Neurotransmitters/Neuropeptides Standard Fmoc-Amino Acids D-Form Amino Acids Resins Peptide Coupling Reagents & Additives Specialty Peptide Building Blocks Pseudoproline Dipeptides Phenylalanine & Tryptophan Unusual Amino Acids & Analogs Newly Launched Small-Molecule Specialties Impurity Analysis & Bioactivity Research Special Offers Peptide Synthesis Chemical Synthesis ADMET Profiling Service AlanMolecularAI AlanDockAI Linear Peptide Optimization Cyclic Peptide Optimization Task Management Knowledge Center News About Us Reagents & Custom Orders Aipower Platform
Sign in
Cart
Search
Home Product Peptide Catalog Products Neuromodulatory and Neuroactive Peptides Neurotransmitters/Neuropeptides α-Neoendorphin (1-7) | YGGFLRK Opioid Peptide Fragment

DESCRIPTION

α-Neo-Endorphin (1-7) is a seven-residue N-terminal fragment of α-Neoendorphin with the sequence Tyr-Gly-Gly-Phe-Leu-Arg-Lys.

The peptide retains the complete Leu-enkephalin motif together with Arg6-Lys7 but removes Tyr8-Pro9-Lys10 from the native decapeptide, producing a compact scaffold for truncation and receptor-address studies.

Product Information

PropertySpecification
Product Nameα-Neo-Endorphin (1-7)
Catalog No.AS2588
SequenceTyr-Gly-Gly-Phe-Leu-Arg-Lys
One-Letter SequenceYGGFLRK
Peptide Length7 residues
Molecular FormulaC40H61N11O9
Molecular WeightApproximately 840.0 Da
C-TerminusLys-OH

A Minimal Basic Extension beyond Leu-Enkephalin

Leu-enkephalin ends after Leu5. α-Neo-Endorphin (1-7) adds Arg6-Lys7, increasing positive charge while keeping the peptide substantially shorter than the native 10-residue sequence.

This makes it useful for dissecting the transition from a short enkephalin-like pharmacophore toward the longer prodynorphin-derived receptor-address architecture.

Comparison with α-Neoendorphin (1-8)

The corresponding 1-8 fragment adds Tyr8. Comparing the two peptides isolates the contribution of a single aromatic residue while keeping the remaining sequence unchanged.

Frequently Asked Questions

Does this peptide contain Tyr8?

No. It terminates at Lys7.

What is the N-terminal opioid motif?

The first five residues are Tyr-Gly-Gly-Phe-Leu, the Leu-enkephalin sequence.

Research Use Only.

α-Neoendorphin (1-7) | YGGFLRK Opioid Peptide Fragment

Catalog No: AS2588

{{ getShowPrice() }} {{ getPrice() }}

Add to Cart Bulk Inquiry
{{ isCollect ? 'Cancel collection' : 'Collection' }}

Related Products

Submit